Formulary
Pancuronium bromide: Indications, Dosing, Side Effects and Interactions
Pancuronium bromide clinical drug profile including indications, dosing, side effects, cautions and interactions.
MedNext Academy | 3 min read
Pancuronium bromide: Indications, Dosing, Side Effects and Interactions
Pancuronium bromide clinical drug profile including indications, dosing, side effects, cautions and interactions.
Indications and dose
**Neuromuscular blockade (long duration) during surgery and intubation**
- **Adult** (By Intravenous Injection): Initially 100 micrograms/kg, then 20 micrograms/kg as required.
**Neuromuscular blockade (long duration) during intensive care**
- **Adult** (By Intravenous Injection): Initially 100 micrograms/kg, initial dose is optional, then 60 micrograms/kg every 60-90 minutes.
**Neuromuscular blockade (long duration) during surgery for pancuronium bromide**
- **Neonate** (By intravenous injection): Initially 100 micrograms/kg, then 50 micrograms/kg, repeated if necessary.
- **Child** (By intravenous injection): Initially 100 micrograms/kg, then 20 micrograms/kg, repeated if necessary.
Cautions
For all non-depolarising neuromuscular blocking drugs Burns (resistance can develop, increased doses may be required); cardiovascular disease (reduce rate of administration); electrolyte disturbances (response unpredictable); fluid disturbances (response unpredictable); hypothermia (activity prolonged, lower doses required); myasthenia gravis (activity prolonged, lower doses required); neuromuscular disorders (response unpredictable)
Side effects
For all non-depolarising neuromuscular blocking drugs Common or very common Flushing; hypotension Uncommon Bronchospasm; hypersensitivity; skin reactions; tachycardia Rare or very rare Circulatory collapse; muscle weakness (after prolonged use in intensive care); myopathy (after prolonged use in intensive care); shock Side-effects For pancuronium bromide Frequency not known Apnoea; arrhythmia; hypersalivation; increased cardiac output; miosis Side-effects, further information Pancuronium lacks histamine-releasing effect, but vagolytic and sympathomimetic effects can cause tachycardia.
Pregnancy
For all non-depolarising neuromuscular blocking drugs Non-depolarising neuromuscular blocking drugs are highly ionised at physiological pH and are therefore unlikely to cross the placenta in significant amounts.
Breast feeding
For all non-depolarising neuromuscular blocking drugs Non-depolarising neuromuscular blocking drugs are ionised at physiological pH and are unlikely to be present in milk in significant amounts. Breast-feeding may be resumed once the mother has recovered from neuromuscular block.
Hepatic impairment
Manufacturer advises caution (possibly slower onset and higher dose requirements due to resistance to neuromuscular blocking action which may lead to a prolonged recovery time).
Renal impairment
Use with caution (may prolong duration of block). M
Medicinal forms
Medicinal forms No licensed medicines listed.
Clinical governance
**Author:** MedNext Clinical Team. **Clinical reviewer:** Dr Shameer Deen, MBBS, MS, MRCS. **Sources:** BNF, Indian Pharmacopoeia, CIMS India. **Correction:** Report errors at support@mednext.academy.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- Growing visual cheat sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Subject HubPharmacology Hub
All pharmacology resources in one place.
Drug SchedulesIndian Drug Schedules
Schedule H, H1, X and G classifications.
FormularyBrowse all drugs
Search 1,850+ drug profiles.
Study Pancuronium bromide in the MedNext app
Challenge yourself with targeted pharmacology MCQs on this drug class. Every explanation links back to the chapter that teaches the concept.
Start drug challengeExplore the full formulary

